Tower Research Capital LLC (Trc) Co Diagnostics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 258 shares of CODX stock, worth $72. This represents 0.0% of its overall portfolio holdings.
Number of Shares
258
Previous 6,232
95.86%
Holding current value
$72
Previous $4,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding CODX
# of Institutions
43Shares Held
5.72MCall Options Held
35.6KPut Options Held
25.9K-
Vanguard Group Inc Valley Forge, PA1.78MShares$497,8900.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$330,8570.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny550KShares$154,0900.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$140,5670.0% of portfolio
-
Geode Capital Management, LLC Boston, MA342KShares$95,8070.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $9.46M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...